Werfen is a family-owned specialized diagnostics company founded in Barcelona in 1966, providing hemostasis, acute care diagnostics, transfusion, autoimmunity and transplant testing to hospitals and laboratories in more than 100 territories. Its automated Aptiva multi-analyte system and ACL TOP hemostasis analyzers anchor a portfolio that spans instruments, reagents and lab data management software.
Further expansion of the Aptiva autoimmunity assay menu
Werfen's Aptiva Antiphospholipid Syndrome IgA Reagent has received both U.S. FDA 510(k) clearance and a CE mark, completing the Aptiva APS portfolio and expanding global access to comprehensive APS testing.
Chief Executive Officer
Chairman